Cowen analyst Gautam Khanna weighed in on General Electric (NYSE: GE) after the company agreed to sell BioPharma unit to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE